$775 Million is the total value of Soleus Capital Management, L.P.'s 65 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EDAP | EDAP TMS S Asponsored adr | $22,827,000 | +21.0% | 3,148,609 | 0.0% | 2.94% | +56.0% | |
| THTX | THERATECHNOLOGIES INC | $18,846,000 | -19.1% | 7,692,082 | 0.0% | 2.43% | +4.2% | |
| BCAB | BIOATLA INC | $12,577,000 | -74.5% | 2,515,424 | 0.0% | 1.62% | -67.2% | |
| CVRX | CVRX INC | $5,763,000 | -51.0% | 962,165 | 0.0% | 0.74% | -36.9% | |
| IO BIOTECH INC | $3,565,000 | -17.2% | 672,734 | 0.0% | 0.46% | +6.7% | ||
| XILIO THERAPEUTICS INC | $3,376,000 | -55.8% | 477,495 | 0.0% | 0.44% | -43.0% | ||
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $2,940,000 | -1.2% | 300,000 | 0.0% | 0.38% | +27.2% | |
| VSTM | VERASTEM INC | $2,319,000 | -31.2% | 1,644,500 | 0.0% | 0.30% | -11.3% | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $1,664,000 | -6.5% | 90,000 | 0.0% | 0.22% | +20.8% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $1,381,000 | -17.2% | 22,000 | 0.0% | 0.18% | +6.6% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $1,170,000 | -18.9% | 1,950,000 | 0.0% | 0.15% | +4.9% | ||
| CELC | CELCUITY INC | $300,000 | -29.1% | 32,073 | 0.0% | 0.04% | -7.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.